{
  "image_filename": "figure_p3_det_2_000.png",
  "image_path": "Treanor_et_al.__2011_/extracted/figures/figure_p3_det_2_000.png",
  "image_type": "Figure",
  "page_number": 3,
  "block_id": "det_2_000",
  "claim_id": "claim_003",
  "claim": "Recombinant technology leads to a broader immune response that may provide cross-protection, even in a mismatch season.",
  "supports_claim": false,
  "explanation": "A flow chart showing subject participation in a study, including numbers randomized, allocated to groups, and the resulting safety populations (n=2344 vs n=2304). The figure only shows participant flow and safety population numbers and does not support the claim about recombinant technology or cross-protective immune responses; it does not support the claim. Note: The image is limited to enrollment and safety population data with no immunogenicity or cross-protection information.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A flow chart showing subject participation in a study, including numbers randomized, allocated to groups, and the resulting safety populations (n=2344 vs n=2304).",
    "evidence_found": null,
    "reasoning": "The figure only shows participant flow and safety population numbers and does not support the claim about recombinant technology or cross-protective immune responses; it does not support the claim.",
    "confidence_notes": "The image is limited to enrollment and safety population data with no immunogenicity or cross-protection information."
  }
}